ABBV ▲ +1.3% - AbbVie Inc. $ABBV - SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026 17-OCT-2026 02:00 AM ET